Firebird Management's Steve Gorelik's Molina Healthcare Bull Thesis $MOH (podcast #342)
In this episode of Yet Another Value Podcast, host Andrew Walker welcomes back Steve Gorelik from Firebird Management for a deep dive into Molina Healthcare (ticker: MOH). Together, they explore the sharp drop in Molina’s stock despite its long-standing compounder reputation. Steve outlines how Molina operates as a low-cost Medicaid-focused managed care organization, making it uniquely resilient amid rising medical costs and regulatory challenges. They discuss Molina’s competitive advantages, risks tied to healthcare policy, redetermination effects, and its strategic M&A playbook. Tune in to understand why Steve believes Molina remains undervalued and poised to outperform its peers—even as the broader Medicaid sector stumbles.
Today’s podcast is sponsored by PortraitAnalytics.AI
Portrait Analytics is a whole new way to use AI in investing. They’ve got a unique set of AI tools that will help you discover, research, and monitor new investment ideas with unprecedented depth. Its AI platform let’s you screen and monitor your portfolio while creating summaries of trends and tailwinds. It’s simple to use, super fast, and really intuitive….. but don’t just take my word for it. I had a listener email me and tell me, “I’ve never thanked anyone for helping me to spend thousands of dollars before, but I never would have heard about portrait analytics without your podcast and I’m just thrilled with how much time it’s feed up for me to do high level analysis and portfolio management.”
Check out Portrait Analytics today and see how they can improve your research process.
Please follow the podcast on Spotify, iTunes, or most other podcast players, as well as on YouTube if you prefer video! And please be sure to rate / review the podcast if you enjoy it, or share it with someone else who would enjoy it (more listeners is a critical part of the flywheel that keeps this Substack and podcast going!).
Disclaimer: Nothing on this podcast or on this blog is investing or financial advice; please see our full disclaimer here. The transcript below is from a third party transcription service; it’s entirely possible there are some errors in the transcript
Transcript for paid subs begins below